Grant: CIHR Fellowship
Direct Payment
$150,000.00
Investigation into the role of antioxidants in breast cancer
FY 2012-13
Summary
Reactive oxygen species (ROS) is produced as a byproduct during generation of energy and production of proteins. At low levels, ROS can promote cell growth and DNA damage, which can benefit a cancer cell. Yet, if it is allowed to accumulate, ROS can become a stress which can lead to cell death. Due to the rapid growth of cancer cells, a high level of energy generation and protein production is required, leading to a high level of ROS generation. In order to quench the buildup of ROS, cancer cells upregulate the synthesis of antioxidants, which convert ROS into non-reactive species, such as water. It was recently shown that by reducing oxidative stress, antioxidants are able to promote cancer cell survival and growth
Advancements in biochemical technology have uncovered numerous changes in genes which are specific to cancer. Interestingly, many of the genes found to be modulated in breast cancer have powerful roles in promoting antioxidant synthesis. Three of the genes found to be changed were glutaminase 2 (GLS2), cystathionase (CTH) and glutamate dehydrogenase 1 (GLUD1). GLS2 and CTH both promote synthesis of glutathione (GSH), the most abundant antioxidant within the cell, while GLUD1 decreases GSH synthesis. Interestingly, expression of both GLS2 and CTH was found to be increased in cancers and GLUD1 expression decreased in cancers
My role in the project will be to elucidate the roles of GLS2, CTH and GLUD1 in breast cancer. It is hypothesized that GLS2 and CTH promote cancer, and GLUD1 prevents it. The significance of this project is enormous as we have the potential discover novel genes which control the growth and survival of breast tumors. Finally, the present proposal has the potential to lead to better treatments for cancer patients. The proteins that I have chosen to investigate are enzymes and considered 'druggable' targets; therefore, this proposal can lead to novel drug targets and improved therapies for cancer patients.
Department
Program
CIHR Fellowship
Recipient
Location
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
281949
Name
Harris Isaac S
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Investigation into the role of antioxidants in breast cancer
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Antioxidants; Breast Cancer; Cell Proliferation; Cell Survival; Genomic Mining; Glutathione (Gsh); Mcf10a Cells; Pik3ca; Pten; Reactive Oxygen Species (Ros)
Abstract
Reactive oxygen species (ROS) is produced as a byproduct during generation of energy and production of proteins. At low levels, ROS can promote cell growth and DNA damage, which can benefit a cancer cell. Yet, if it is allowed to accumulate, ROS can become a stress which can lead to cell death. Due to the rapid growth of cancer cells, a high level of energy generation and protein production is required, leading to a high level of ROS generation. In order to quench the buildup of ROS, cancer cells upregulate the synthesis of antioxidants, which convert ROS into non-reactive species, such as water. It was recently shown that by reducing oxidative stress, antioxidants are able to promote cancer cell survival and growth
Advancements in biochemical technology have uncovered numerous changes in genes which are specific to cancer. Interestingly, many of the genes found to be modulated in breast cancer have powerful roles in promoting antioxidant synthesis. Three of the genes found to be changed were glutaminase 2 (GLS2), cystathionase (CTH) and glutamate dehydrogenase 1 (GLUD1). GLS2 and CTH both promote synthesis of glutathione (GSH), the most abundant antioxidant within the cell, while GLUD1 decreases GSH synthesis. Interestingly, expression of both GLS2 and CTH was found to be increased in cancers and GLUD1 expression decreased in cancers
My role in the project will be to elucidate the roles of GLS2, CTH and GLUD1 in breast cancer. It is hypothesized that GLS2 and CTH promote cancer, and GLUD1 prevents it. The significance of this project is enormous as we have the potential discover novel genes which control the growth and survival of breast tumors. Finally, the present proposal has the potential to lead to better treatments for cancer patients. The proteins that I have chosen to investigate are enzymes and considered 'druggable' targets; therefore, this proposal can lead to novel drug targets and improved therapies for cancer patients.
Competitiondate
201302
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Harris, Isaac S
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~